Bruce Freeman, PhD is the Irwin Fridovich Distinguished Professor and Chair of the Department of Pharmacology and Chemical Biology at the University of Pittsburgh School of Medicine. He has extensive experience in the biochemistry and pharmacology of nitric oxide signaling and oxidative inflammatory reactions. He and his research team have pioneered the discovery of potent inflammatory and cell signaling mediators, that are now being translated into new therapeutic strategies by Complexa, Inc.